Quick Search

  Wholesaler/Distributor Registration   l  My Cart   l   My Account  l  Home

 
Brands
  Pharmacist Nutriceuticals®
  USA Best®
  USA LABORATORIES®
  USA SPORTS LABS®
Products
  Health Concerns
  Sexual Health
  Specialty Supplements
  Vitamins & Minerals
  --------------------------------------------
  Weight Loss
  --------------------------------------------
  Children's
  --------------------------------------------
  Female
  Male
  --------------------------------------------
  Sports & Athletic Nutrition
  Extreme Hardcore Body Building
  Body Shaping
  Amino Acids
  Proteins
  Carbohydrates
  --------------------------------------------
  Food Bars
  --------------------------------------------
  Branded Ingredients
  --------------------------------------------
  Press Releases
  --------------------------------------------
  Employment
  Company Policy
2001 NITRO EGG AMINO™ [click to enlarge]
USASL2ENA250T - 15.75X12X8 19#

MSRP: $45.99
Internet Direct: $39.99

Bottles:


2001 NITRO EGG AMINO™


"Nutrition, Champion Athletes Get It!"


250 Tablets Pure Egg White 2000mg per tablet. HIGHEST GRADE 3.9 PROTEIN EFFICIENCY RATIO Amino Acids with Chromium Picolinate for Nitrogen and Insulin Pump and More!

PHARMACIST REFERENCES:


Protein References:
1. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids (macronutrients). National Academy Press.
2. USDA Nutrient Database for Standard Reference, Release 14. US Department of Agriculture.
3. World Cancer Research Fund, American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. Washington DC: AICR, 2007.
4. Halton TL, Willett WC, Liu S, et al. Low-carbohydrate-diet score and the risk of coronary heart disease in women. N Engl J Med. 2006; 355:1991–2002.
5. Akerblom HK, Vaarala O, Hyoty H, Ilonen J, Knip M. Environmental factors in the etiology of type 1 diabetes. Am J Med Genet. 2002; 115:18–29.
6. Feskanich D, Willett WC, Stampfer MJ, Colditz GA. Protein consumption and bone fractures in women. Am J Epidemiol. 1996; 143:472–9.
7. Foster GD, Wyatt HR, Hill JO, et al. A randomized trial of a low–carbohydrate diet for obesity. N Engl J Med. 2003; 348:2082–90.
8. Samaha FF, Iqbal N, Seshadri P, et al. A low-carbohydrate as compared with a low–fat diet in severe obesity. N Engl J Med. 2003; 348:2074–81.
9. Gardner CD, Kiazand A, Alhassan S, et al. Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women: the A TO Z Weight Loss Study: a randomized trial. JAMA. 2007; 297:969–77.
10. Halton TL, Hu FB. The effects of high protein diets on thermogenesis, satiety and weight loss: a critical review. J Am Coll Nutr. 2004; 23:373–85.
11. Health claims: Soy protein and risk of coronary heart disease. Code of Federal Regulations 21CFR101.82 (2001).
12. Sacks FM, Lichtenstein A, Van Horn L, Harris W, Kris–Etherton P, Winston M. Soy protein, isoflavones, and cardiovascular health. An American Heart Association science advisory for professionals from the nutrition committee. Circulation. 2006.
13. Anderson JW, Johnstone BM, Cook–Newell ME. Meta–analysis of the effects of soy protein intake on serum lipids. N Engl J Med.1995; 333:276–82.
14. Krebs EE, Ensrud KE, MacDonald R, Wilt TJ. Phytoestrogens for treatment of menopausal symptoms: a systematic review. Obstet Gynecol. 2004; 104:824–36.
15. Kronenberg F, Fugh-Berman A. Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials. Ann Intern Med. 2002; 137:805–13.
16. Trock BJ, Hilakivi-Clarke L, Clarke R. Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst. 2006; 98:459–71.
17. Michels KB, Mohllajee AP, Roset–Bahmanyar E, Beehler GP, Moysich KB. Diet and breast cancer: a review of the prospective observational studies. Cancer. 2007; 109:2712–49.
18. Linos E, Willett WC. Diet and breast cancer risk reduction. J Natl Compr Canc Netw. 2007; 5:711–718.
19. de Lemos ML. Effects of soy phytoestrogens genistein and daidzein on breast cancer growth. Ann Pharmacother 2001; 35:1118–21.
20. Allred CD, Allred KF, Ju YH, Virant SM, Helferich WG. Soy diets containing varying amounts of genistein stimulate growth of estrogen–dependent (MCF-7) tumors in a dose–dependent manner. Cancer Res. 2001; 61:5045–50.
21. Kritz–Silverstein D, Von Muhlen D, Barrett-Connor E, Bressel MA. Isoflavones and cognitive function in older women: the SOy and Postmenopausal Health In Aging (SOPHIA) Study. Menopause. 2003; 10:196–202.
22. Kreijkamp-Kaspers S, Kok L, Grobbee DE, et al. Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial. JAMA. 2004; 292:65–74.
23. Fournier LR, Ryan Borchers TA, Robison LM, et al. The effects of soy milk and isoflavone supplements on cognitive performance in healthy, postmenopausal women. J Nutr Health Aging. 2007; 11:155–64.
24. Ho SC, Chan AS, Ho YP, et al. Effects of soy isoflavone supplementation on cognitive function in Chinese postmenopausal women: a double-blind, randomized, controlled trial. Menopause. 2007; 14:489–99.

L-Lysine References:
1. Civitelli R, Villareal DT, Agneusdei D, et al. Dietary L-lysine and calcium metabolism in humans. Nutrition 1992;8:400-404.
2. Pauling L. Case report: Lysine/ascorbate-related amelioration of angina pectoris. J Orthomol Med 1991;6:144-46.
3. Flodin NW. The metabolic roles, pharmacology, and toxicology of lysine. J Am Coll Nutr 1997;16:7-21 [review].
4. Kritchevsky D, Weber MM, Klurfeld DM. Gallstone formation in hamsters: influence of specific amino acids. Nutr Rep Internat 1984;29:117.
5. Leszcynski DE, Kummerow FA. Excess dietary lysine induces hypercholestrolemia in chickens. Experientia 1982;38:266-67.

L-Glutamine References:
1. Damrau F. Benign prostatic hypertrophy: Amino acid therapy for symptomatic relief. j Am Gariatric Soc 1962;10(5):426-30.
2. Feinblatt HM, Gant JC. Palliative treatment of benign prostatic hypertrophy. Value of glycine-alanine-glutamic acid combination. J Maine Med Assoc Mar 1958.
3. Zello GA, Wykes LF, Ball RO, et al. Recent advances in methods of assessing dietary amino acid requirements for adult humans. J Nutr 1995;125:2907-15.

L-Alanine References:
1. Damrau F. Benign prostatic hypertrophy: Amino acid therapy for symptomatic relief. j Am Gariatric Soc 1962;10(5):426-30.
2. Feinblatt HM, Gant JC. Palliative treatment of benign prostatic hypertrophy. Value of glycine-alanine-glutamic acid combination. J Maine Med Assoc Mar 1958.
3. Zello GA, Wykes LF, Ball RO, et al. Recent advances in methods of assessing dietary amino acid requirements for adult humans. J Nutr 1995;125:2907-15.

L-Glycine References:
1. Damrau F. Benign prostatic hypertrophy: Amino acid therapy for symptomatic relief. J Am Geriatric Soc 1962;10(5):426-30.
2. Feinblatt HM, Gant JC. Palliative treatment of benign prostatic hypertrophy. Value of glycine-alanine-glutamic acid combination. j Maine Med Assoc Mar 1958.

L-Methionine References:
1. Muller f et al. Elevated plasma concentration of reduced homocysteine in patients with Human Immunodeficiency Virus infection. Am J Clin Nutr 1996;242-46.
2. Revillard JP. Lipid peroxidation in Human immunodefeciency Virus infection. J Acquired Immunode Synd 1992;5:637-38.
3. Singer P et al. Nutritional aspects of the Acquired Immunodefeciency Syndrome. Am J Gastroenter 1992;87:265-73.
4. Tan SV, Guiloff RJ. Hypothesis on the pathongenesis of vacuolar myelopathy, dementia, and peripheral neuropathy in AIDS. J Neurol Neurosurg Psychiat 1998 65:23-25.
5. Keating JN et al. Evidences of brain methyltransferase inhibition and early brain involvement in HIV-positive patients. Lancet 1991;337:935-39.
6. Dorfman D, DiRocco A, Simpson D, et al. Oral methionine may improve neuropsychological function in patients with AIDS myelopathy: results of an open-label trial. AIDS 1997;11:1066-67.
7. Smythies JR, Halsey JH. Treatment of Parkinson's disease with l-methionine. Shouth Med J 1974;77:1577.
8. Uden S, Bilton D, Nathan L, et al. Antioxidant therapy for recurrent pancreatitis: placebo-controlled trial. Aliment Pharmacol Ther 1990;4:357-71.
9. Shaw GM, Velle EM, Schaffer DM. Is dietary intake of methionine associated with a reduction in risk for neural tube defect-associated pregnancies? Teratology
1997;56:295-99.
10. Toborek M, Hennig B. Is methionine an atherogenci amino acid? J Optimalt Nutr 1994;3(2):80-8.
11. Leach FN, Braganza JM. Methionine is important in treatment of chronic pancreatitis. Br Med J 1998;316:474 [letter].

L-Phenylalanine References:
1. Sabeli HC. Clinical studies on the phenylethylamine hypothesis of affective disorder: urine and blood phenylacetic acid and phenylalanine dietary supplements. J Clin Psychaiatry 1986;47:66-70.
2. Fischer E. et at. Therapy of depression by phenylalanine. Arzeimittelforsch 1975;25:132.
3. Heller B et al. Therapeutic action of D-phenylalanine in Parkinson's disease. Arzeimittelforsch 1976;26:577-79.
4. Budd K. Use of D-phenylalanine, an enkephalinase inhibitor, in the treatment of itractable pain. Pain Res Ther 1983;5:305-8.
5. Anonymous. Phenylanine fails to help chronic back pain patients. Family Pract News 1987;17(3):37.

Vitamin B6 References:
1. Keniston RC, Nathan PA, Leklem JE, Lockwood Rs. Vitamin B6, vitamin C, and carpal tunnel syndrome. J Occup Environ Med 1997;39:949-59.
2. Franzblau A, Rock CL, Werner RA, et al. The relationship of vitamin B6 status to median nerve function and carpal tunnel syndrome among active industrial workers. J Occup Environ Med 1996;38:485-91.
3. Smith GP, Rudge PJ, Peters TJ. Biochemical studies of pyridoxal and pyridoxal phosphate status and therapeutic trial of pyridoxine in patients with carpal tunnel syndrome. Ann Neurol 1984;15:104-107.
4. Gaby AR. Literature review & commentary. Townsend Letter for Doctors June 1990;338-39.
5. Parry G, Bredesen DE. Sensory neuropath with low-dose pyridoxine. Neurology 1985;35:1466-68.
6. Schaumburg H, Kaplan J, Windebank A, et al. Sensory neuropathy from pyridoxine abuse. N England Med 1983;309(8):445-48.

Ornithine References:
1. Bucci LR, Hickson JF. Wolinsky l, et al. Ornithine supplementation and insulin release in bodybuilders. Int J Sport Nutr 1992;2:287-91.
2. Fogelhom GM, Naveri HK, Killavouri KT, et al. Low-dose amino acid supplementation: no effects of serum human growth hormone and insulin in male weightlifters. Int J Sport Nutr 1993;3:290-97.
3. Lambert MI, Hefer JA, Millar RP, et al. Failure of commercial oral amino acid supplements to increase serum growth hormone concentrations in male boly-builders. Int J Sport Nutr 1993;3:298-305.
4. Bucci L, Hickson JF et al. Ornithine ingestion and growth hormone release in bodybuilders. Nutr R 1990;10:239-45.
5. Elam RP, Hardin DH, Sutton RA, et al. Effects of arginine and ornithine on strength, lean body mass and urinary hydroxproline in adult males. J Sports Med Phys Fitness 1989;29:52-56.
6. Zieve L. Conditional deficiencies of ornithine or arginie. J Am Coll Nutr 1986;5:167-79. [Review].

L-Arginine References:
1. Besset A, Bonardet A, Rondouin G, et al. Increase in sleep related GH and Pri secretion after chron. argnine aspartate adminstration in man. Acta Endocrinologica 1982;99:18-23.
2. Elam RP. Morphological changes in adult males from resistance exercise and amino acid supplementation. J Sports Med Phys Fitness 1988;28:35-39.
3. Schacter A, Goldman JA, Zukerman Z. Treatment of oligospermia with the amino acid arginine. J Urol 1973;110:311-13.
4. Pryor JP, Blandy JP, Evans P, et al. Controlled clinical trial of arginine for infertile men with loigozoospermia. Br J Urol 1978;50:47059.
5. Barbul A, Rettura G, Levenson SM, et al. Wound healing and thymotropic effects argine: a pituitary mechanism of action. Am J Clin Nutr 1983;37:786-94.
6. Kirk SJ, Hurson M, Regan MC, et al. Arginine stimulates wound healing and immune function in elderly human beings. Surgery 1993;114:155-60.
7. Kohls KJ, Kies C, Fox HM. Serum lipid levels of humans given argine, lysine and tryptophan supplements without food. Nutr Rep Internat 1987;35:5-13.
8. Wolf A, Zalpour C, Theilmeier G, et al. Dietary L-arginine supplementation normalizes platelet aggregation in hypercholesterolemic humans. J Am Coll Cardiol 1997;29:479-85.
9. Smith SD, Wheeler MA, Foster HE Jr. Weiss RM. Improvement in interstitial cystitis symptom score during treatment with oral K-arginine. J Urol 1997;158:703-8.
10. Park KGM. The immunological and metabolic effects of L-arginine in human cancer. Proc Nutr Sci 1993;52:387-401.
11. Takeda Y, Tominga T, Tei N, et al. Inhibitory effect of L-arginine on growth fo rat mammary tumor induced by 7, 12, Dimethylbenz(a)anthracine. Cancer Res 1975;35:390-93.
12. Brittenden J, Park KGM, Heys SD, et al. L-arginine stimulates host defenses in patients with breast cancer. Surgery 1994;115:205-12.

Cysteine References:
1. Salim AS. Sulfhydryl-containing agents in the treatment of gastric bleeding induced by nonsteroidal anti-inflammatory drugs. Can j Surgery 1993;36:53-58.
2. Droge W, Eck HP, Gander H, Mihm S. Modulation of lymphocyte functions and immune response by cysteine and cysteine derivatives. Am J Med 1991;91(suppl 3C): 140S-44S.
3. Eck HP, Gander H, Hartmann M, et al. Biol Chem Hoppe Seyler 1989;370:101-8.
4. Droge W, Eck HP, Mihm S. HIV-induced cysteine deficiency and T-cell dysfunction--a rationale for treatment with N-acteylcysteine. Immunol Today 1992;13:211-14.
5. Droge W. Cysteine and glutathione deficiency in AIDS patients: A rationale for the treatment with N-acetyl-cysteine. Pharmacol 1993;46:61-65.
6. Kleinveld HA, Demacker PNM, Stalenhoef AFH. Failure of N-acetylcysteine to reduce low-density lipoprotein oxidizability in healthy sugjects. Eur J Clin Pharmacol 1992;639-42.
7. Olney JW, Ho O-L. Brain damage in infant mice following oral intake of glutamante, aspartate or cysteine. Nature 1970;227:609-10 [letter].

Chromium References:
1. Saner G, Yüzbasiyan V, Neyzi O, et al. Alterations of chromium metabolism and effect of chromium supplementation in Turner's syndrome patients. Am J Clin Nutr 1983;38:574-78.
2. Riales R, Albrink MJ. Effect of chromium chloride supplementation on glucose tolerance and serum lipids including high-density lipoprotein of adult men. Am J Clin Nutr 1981;34:2670-78.
3. Wang MM, Fox EZ, Stoecker BJ, et al. Serum cholesterol of adults supplemented with brewer's yeast or chromium cholride. Nutr Res 1989;9:989-98.
4. Page TG, Ward TL, and Southern LL. Effect of chromium picolinate on growth and carcass characteristics of growing-finishing pigs. J Animal Sci 1991;69:356.
5. Lefavi R, Anderson R, Keith R, et al. Efficacy of chromium supplementation in athletes: Emphasis on anabolism. Int J Sport Nutr 1992;2:111-22.
6. McCarty MF. The case for supplemental chromium and a survey of clinical studies with chromium picolinate. J Appl Nutr 1991;43:59-66.
7. Hallmark MA, Reynolds TH, DeSouza CA, et al. Effects of chromium and resistive training on muscle strength and body composition. Med Sci Spt Ex 1996;28:139-44.
8. Kaats GR, Blum K, Fisher JA, Adelman JA. Effects of chromium picolinate supplementation on body composition: a randomized, double-masked, placebo-controlled study. Curr Ther Res 1996;57:747-51.
9. Kaats GR, Blum K, Pullin D, Keither SC, Wood R. A randomized, double-masked, placebo-control study of the effects of chromium picolinate supplementation on body composition: a replication and extension of a previous study. Curr Ther Res 1998;59:379-88.
10. Sterns DM, Belbruno JJ, Wetterhahn KE. A prediction of chromium (III) accumulation in humans from chromium dietary supplements. FASEB J 1995;9:1650-57.
11. Sterns DM, Wise JP, Patierno SR, Wetterhahn KE. Chromium (III) picolinate produces chromosl damage in Chinese hamster ovary cells. FASEB J 1995;9:1643-49.
12. Garland M, Morris JS, Colditz GA, et al. Toenail trace element levels and breat cancer. AmJ Epidemiol 1996;144:653-60.
13. Cerulli J, Grabe DW, Guathier I, et al. Chromium picolinate toxicity. Ann Pharmacother 1998;32:428-31.
14. Wasser WG, Feldman NS. Chromic renal failure after ingestion of over-the-counter chromium picolinate. Ann Intern Med 1997;126:410 [letter].
15. Offenbacher EG. Promotion of chromium absorption by ascorbic acid. Trace Elements Electrolyte 1994;11:178-81.


  • Back To List
  • Wholesaler/Distributor Registration   l  My Cart   l   My Account  l  Home  l  Return to Top of Page

        Nasvhille Chamber of Commerce Dickson County Chamber of Commerce U.S. Commercial Service

    *These statements have not been evaluated by the F.D.A. *USA Laboratories makes no representation or warranties concerning the use of our products for the diagnosis, cure, mitigation, treatment or prevention of any disease. *Seek advice from a health care provider before using this or any supplement product.

    Powered By LionZone Copyright © USA LABORATORIES, INC. All rights reserved.